ArticleAnnals of clinical microbiology and antimicrobials2017

PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.

Anamika Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.